DD110271A5 - - Google Patents

Info

Publication number
DD110271A5
DD110271A5 DD174561A DD17456173A DD110271A5 DD 110271 A5 DD110271 A5 DD 110271A5 DD 174561 A DD174561 A DD 174561A DD 17456173 A DD17456173 A DD 17456173A DD 110271 A5 DD110271 A5 DD 110271A5
Authority
DD
German Democratic Republic
Application number
DD174561A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19722255439 external-priority patent/DE2255439A1/de
Priority claimed from DE19732349639 external-priority patent/DE2349639A1/de
Application filed filed Critical
Publication of DD110271A5 publication Critical patent/DD110271A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD174561A 1972-11-11 1973-11-09 DD110271A5 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19722255439 DE2255439A1 (de) 1972-11-11 1972-11-11 Neue cyclobutan-derivate
DE19732349639 DE2349639A1 (de) 1973-10-03 1973-10-03 Neue cyclobutan-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD110271A5 true DD110271A5 (en:Method) 1974-12-12

Family

ID=25764071

Family Applications (1)

Application Number Title Priority Date Filing Date
DD174561A DD110271A5 (en:Method) 1972-11-11 1973-11-09

Country Status (18)

Country Link
US (1) US3931185A (en:Method)
JP (1) JPS49133383A (en:Method)
AT (1) AT334903B (en:Method)
BG (1) BG23007A3 (en:Method)
CA (1) CA999297A (en:Method)
CH (2) CH587253A5 (en:Method)
DD (1) DD110271A5 (en:Method)
ES (1) ES427559A1 (en:Method)
FR (1) FR2206094B1 (en:Method)
GB (1) GB1410303A (en:Method)
HU (1) HU167390B (en:Method)
IE (1) IE38868B1 (en:Method)
NL (1) NL7314672A (en:Method)
PH (1) PH10668A (en:Method)
PL (2) PL91170B1 (en:Method)
RO (1) RO64593A (en:Method)
SU (2) SU524516A3 (en:Method)
ZA (1) ZA738606B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9300194D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265724A (en:Method) 1960-06-09

Also Published As

Publication number Publication date
SU561513A3 (ru) 1977-06-05
NL7314672A (en:Method) 1974-05-14
PL92386B1 (en:Method) 1977-04-30
ZA738606B (en) 1974-11-27
US3931185A (en) 1976-01-06
PH10668A (en) 1977-08-02
IE38868B1 (en) 1978-06-21
AT334903B (de) 1977-02-10
JPS49133383A (en:Method) 1974-12-21
FR2206094A1 (en:Method) 1974-06-07
CH587253A5 (en:Method) 1977-04-29
CA999297A (en) 1976-11-02
IE38868L (en) 1974-05-11
RO64593A (ro) 1980-06-15
FR2206094B1 (en:Method) 1976-10-22
AU6235773A (en) 1975-05-15
SU524516A3 (ru) 1976-08-05
ES427559A1 (es) 1976-08-01
BG23007A3 (bg) 1977-05-20
PL91170B1 (en:Method) 1977-02-28
CH602669A5 (en:Method) 1978-07-31
GB1410303A (en) 1975-10-15
ATA943373A (de) 1976-06-15
HU167390B (en:Method) 1975-09-27

Similar Documents

Publication Publication Date Title
CS161817B2 (en:Method)
JPS4913017A (en:Method)
FR2206094A1 (en:Method)
JPS4973497U (en:Method)
JPS515181Y2 (en:Method)
JPS4921617U (en:Method)
JPS5214924Y2 (en:Method)
JPS548800Y2 (en:Method)
CS162140B1 (en:Method)
CS161367B1 (en:Method)
JPS48114519U (en:Method)
CS152690B1 (en:Method)
JPS48106961U (en:Method)
CS156136B1 (en:Method)
JPS4978599U (en:Method)
CS154487B1 (en:Method)
CS160339B1 (en:Method)
CS153919B1 (en:Method)
CH599224A5 (en:Method)
CH587602A5 (en:Method)
CH566258A5 (en:Method)
CH566534A5 (en:Method)
CH568085A5 (en:Method)
CH575946A5 (en:Method)
CH572344A5 (en:Method)